Nuvectis Pharma Inc (NVCT)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NVCT market cap is 91.58M. The company's latest EPS is USD -1.1521 and P/E is -4.14.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.16M | -6.87M | -4.4M | -4.64M | -4.36M |
| Net Income | -5.88M | -6.62M | -4.17M | -4.43M | -4.15M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -10k | -12.89M | -19.23M | -22.9M |
| Net Income | -10k | -12.89M | -19.09M | -22.26M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 22.26M | 19.19M | 19.71M | 18.3M | 17.31M |
| Total Liabilities | 5.58M | 6.98M | 5.69M | 5.77M | 6.32M |
| Total Equity | 16.69M | 12.2M | 14.02M | 12.53M | 10.99M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 0 | 6.66M | 20.41M | 19.19M |
| Total Liabilities | 10k | 2.42M | 6.19M | 6.98M |
| Total Equity | -10k | -11.01M | 14.22M | 12.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -12.1M | -15.95M | -4.36M | -7.38M | -9.78M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 14.17M | 15.09M | 4.7M | 6.37M | 7.83M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | -9.5M | -13.56M | -15.95M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | N/A | 15.25M | 27.81M | 15.09M |
| Market Cap | 91.58M |
| Price to Earnings Ratio | -4.14 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.82 |
| Price to Book Ratio | 7.55 |
| Dividend Yield | - |
| Shares Outstanding | 19.32M |
| Average Volume (1 week) | 103.38k |
| Average Volume (1 Month) | 92.88k |
| 52 Week Change | -44.30% |
| 52 Week High | 12.10 |
| 52 Week Low | 4.44 |
| Spread (Intraday) | 0.05 (1.05%) |
| Company Name | Nuvectis Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.nuvectis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
